Publications list for Dr Leanne Stokes

2011 | 2010 | 2009 | 2008 | 2007 | 2006

2011

   
  • Stokes, L., Scurrah, K., Ellis, J., Cromer, B., Skarratt, K., Gu, B., Harrap, S., Wiley, J. (2011), A Loss-of-Function Polymorphism in the Human P2X4 Receptor Is Associated With Increased Pulse Pressure. Hypertension. 58(6), 1086-92. [Abstract]
  • Wiley, J., Sluyter, R., Gu, B., Stokes, L., Fuller, S. (2011), The human P2X7 receptor and its role in innate immunity. Tissue Antigens. 78(5), 321-332. [Abstract]
  • Sluyter, R., Stokes, L. (2011), Significance of P2X7 receptor variants to human health and disease. Recent Patents on DNA & Gene Sequences. 5(1), 41-54. [Abstract]

2010

   
  • Sluyter, R., Stokes, L., Fuller, S., Skarratt, K., Gu, B., Wiley, J. (2010), Functional significance of P2RX7 polymorphisms associated with affective mood disorders. Journal of psychiatric research. , 1116-7. [Abstract]
  • Stokes, L., Fuller, S., Sluyter, R., Skarratt, K., Gu, B., Wiley, J. (2010), Two haplotypes of the P2X7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1{beta} secretion. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 24(8), 2916-27. [Abstract]

2009

   
  • Gu, B., Rathsam, C., Stokes, L., McGeachie, A., Wiley, J. (2009), Extracellular ATP dissociates nonmuscle myosin from P2X(7) complex: this dissociation regulates P2X(7) pore formation. American journal of physiology. Cell physiology. 297(2), C430-9. [Abstract]
  • Fuller, S., Stokes, L., Skarratt, K., Gu, B., Wiley, J. (2009), Genetics of the P2X7 receptor and human disease. Purinergic signalling. 5(2), 257-262. [Abstract]
  • Stokes, L., Surprenant, A. (2009), Dynamic regulation of the P2X4 receptor in alveolar macrophages by phagocytosis and classical activation. European Journal of Immunology. 39(4), 986-995. [Abstract]

2008

   
  • Shemon, A., Sluyter, R., Stokes, L., Manley, P., Wiley, J. (2008), Inhibition of the human P2X(7) receptor by a novel protein tyrosine kinase antagonist. Biochemical and biophysical research communications. 365(0), 515-20. [Abstract]

2007

   
  • Vaughan, K., Stokes, L., Prince, L., Marriott, H., Meis, S., Kassack, M., Bingle, C., Sabroe, I., Surprenant, A., Whyte, M. (2007), Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. Journal of immunology. 179(12), 8544-8553. [Abstract]
  • Stokes, L., Surprenant, A. (2007), Purinergic P2Y2 receptors induce increased MCP-1/CCL2 synthesis and release from rat alveolar and peritoneal macrophages. Journal of immunology. 179(9), 6016-6023. [Abstract]
  • Wilson, H., Varcoe, R., Stokes, L., Holland, K., Francis, S., Dower, S., Surprenant, A., Crossman, D. (2007), P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cells. British journal of pharmacology. 151(1), 115-127. [Abstract]

2006

   
  • Stokes, L., Jiang, L., Alcaraz, L., Bent, J., Bowers, K., Fagura, M., Furber, M., Mortimore, M., Lawson, M., Theaker, J., Laurent, C., Braddock, M., Surprenant, A. (2006), Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. British journal of pharmacology. 149(7), 880-887. [Abstract]